Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TCF12
|
ENSG00000140262.18 | transcription factor 12 |
ASCL2
|
ENSG00000183734.5 | achaete-scute family bHLH transcription factor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ASCL2 | hg38_v1_chr11_-_2270584_2270595 | 0.20 | 2.8e-01 | Click! |
TCF12 | hg38_v1_chr15_+_56919120_56919165 | -0.12 | 5.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_-_37486357 | 6.81 |
ENST00000356998.8
ENST00000416983.7 ENST00000424765.2 |
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr5_-_177509814 | 6.68 |
ENST00000510898.7
ENST00000502885.5 ENST00000506493.5 |
DOK3
|
docking protein 3 |
chr1_+_27342014 | 6.56 |
ENST00000618673.4
ENST00000318074.9 ENST00000616558.5 |
SYTL1
|
synaptotagmin like 1 |
chr2_+_90234809 | 6.06 |
ENST00000443397.5
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chr14_-_106335613 | 5.70 |
ENST00000603660.1
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
chr16_+_32066065 | 5.69 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
chr14_-_106130061 | 5.59 |
ENST00000390602.3
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
chr14_-_106349792 | 5.49 |
ENST00000438142.3
|
IGHV4-31
|
immunoglobulin heavy variable 4-31 |
chr2_+_90172802 | 5.42 |
ENST00000390277.3
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
chr14_-_106324743 | 5.39 |
ENST00000390612.3
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
chr5_-_177509843 | 5.37 |
ENST00000510380.5
ENST00000357198.9 |
DOK3
|
docking protein 3 |
chr2_-_157488829 | 5.25 |
ENST00000435117.1
ENST00000439355.5 |
CYTIP
|
cytohesin 1 interacting protein |
chr14_-_106803221 | 5.08 |
ENST00000390636.2
|
IGHV3-73
|
immunoglobulin heavy variable 3-73 |
chr2_-_89027700 | 4.96 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
chr14_-_106658251 | 4.93 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
chr14_-_106627685 | 4.84 |
ENST00000390629.3
|
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
chr22_+_22792485 | 4.82 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr9_-_35619542 | 4.73 |
ENST00000396757.6
|
CD72
|
CD72 molecule |
chr22_+_22162155 | 4.68 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
chr2_-_88947820 | 4.68 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr2_+_87338511 | 4.67 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
chr21_-_44910630 | 4.60 |
ENST00000320216.10
ENST00000397852.5 |
ITGB2
|
integrin subunit beta 2 |
chr22_+_22811737 | 4.45 |
ENST00000390315.3
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
chr14_-_91417805 | 4.37 |
ENST00000389857.11
ENST00000553403.1 |
CCDC88C
|
coiled-coil domain containing 88C |
chr20_+_46008900 | 4.32 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 |
chr22_+_22375984 | 4.31 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
chr17_+_36103819 | 4.17 |
ENST00000615863.2
ENST00000621626.1 |
CCL4
|
C-C motif chemokine ligand 4 |
chr5_-_95284535 | 4.16 |
ENST00000515393.5
|
MCTP1
|
multiple C2 and transmembrane domain containing 1 |
chr14_-_106715166 | 4.13 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
chr1_+_206507546 | 4.10 |
ENST00000580449.5
ENST00000581503.6 |
RASSF5
|
Ras association domain family member 5 |
chr2_+_90114838 | 4.09 |
ENST00000417279.3
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 |
chr1_+_206507520 | 4.08 |
ENST00000579436.7
|
RASSF5
|
Ras association domain family member 5 |
chr16_+_23835946 | 4.03 |
ENST00000321728.12
ENST00000643927.1 |
PRKCB
|
protein kinase C beta |
chr4_-_25863537 | 3.89 |
ENST00000502949.5
ENST00000264868.9 ENST00000513691.1 ENST00000514872.1 |
SEL1L3
|
SEL1L family member 3 |
chr15_+_88639009 | 3.85 |
ENST00000306072.10
|
ISG20
|
interferon stimulated exonuclease gene 20 |
chr11_+_60455839 | 3.77 |
ENST00000532491.5
ENST00000532073.5 ENST00000345732.9 ENST00000534668.6 ENST00000528313.1 ENST00000533306.6 ENST00000674194.1 |
MS4A1
|
membrane spanning 4-domains A1 |
chr20_+_38805686 | 3.74 |
ENST00000299824.6
ENST00000373331.2 |
PPP1R16B
|
protein phosphatase 1 regulatory subunit 16B |
chr1_-_27635176 | 3.72 |
ENST00000374005.8
|
FGR
|
FGR proto-oncogene, Src family tyrosine kinase |
chr5_-_151224069 | 3.67 |
ENST00000355417.7
|
CCDC69
|
coiled-coil domain containing 69 |
chr15_-_19965101 | 3.61 |
ENST00000338912.5
|
IGHV1OR15-9
|
immunoglobulin heavy variable 1/OR15-9 (non-functional) |
chr15_+_88638947 | 3.57 |
ENST00000559876.2
|
ISG20
|
interferon stimulated exonuclease gene 20 |
chr22_+_22343185 | 3.56 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
chr21_+_29130630 | 3.54 |
ENST00000399926.5
ENST00000399928.6 |
MAP3K7CL
|
MAP3K7 C-terminal like |
chr17_-_41118369 | 3.36 |
ENST00000391413.4
|
KRTAP4-11
|
keratin associated protein 4-11 |
chr14_-_106235582 | 3.29 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
chr1_-_153550083 | 3.28 |
ENST00000368714.1
|
S100A4
|
S100 calcium binding protein A4 |
chr16_+_67645100 | 3.28 |
ENST00000334583.11
|
CARMIL2
|
capping protein regulator and myosin 1 linker 2 |
chr14_-_106538331 | 3.28 |
ENST00000390624.3
|
IGHV3-48
|
immunoglobulin heavy variable 3-48 |
chr2_-_88979016 | 3.24 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr21_+_29130961 | 3.23 |
ENST00000399925.5
|
MAP3K7CL
|
MAP3K7 C-terminal like |
chr2_-_86790825 | 3.22 |
ENST00000409781.1
ENST00000352580.7 |
CD8A
|
CD8a molecule |
chr17_+_41105332 | 3.18 |
ENST00000391415.1
ENST00000617453.1 |
KRTAP4-9
|
keratin associated protein 4-9 |
chr2_-_196171565 | 3.15 |
ENST00000263955.9
|
STK17B
|
serine/threonine kinase 17b |
chr10_-_96720485 | 3.15 |
ENST00000339364.10
|
PIK3AP1
|
phosphoinositide-3-kinase adaptor protein 1 |
chr11_+_118344318 | 3.13 |
ENST00000392883.6
ENST00000532917.3 ENST00000528540.5 |
CD3G
|
CD3g molecule |
chr11_+_1870871 | 3.12 |
ENST00000417766.5
|
LSP1
|
lymphocyte specific protein 1 |
chr16_+_67645166 | 3.11 |
ENST00000545661.5
|
CARMIL2
|
capping protein regulator and myosin 1 linker 2 |
chr14_-_105856183 | 3.10 |
ENST00000637539.2
ENST00000390559.6 |
IGHM
|
immunoglobulin heavy constant mu |
chr2_-_89085787 | 3.09 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr2_-_37672178 | 3.07 |
ENST00000457889.1
|
CDC42EP3
|
CDC42 effector protein 3 |
chr2_+_88885397 | 3.02 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
chr4_+_73853290 | 3.01 |
ENST00000226524.4
|
PF4V1
|
platelet factor 4 variant 1 |
chr17_+_78169127 | 3.00 |
ENST00000590201.1
|
SYNGR2
|
synaptogyrin 2 |
chr12_+_6444932 | 2.98 |
ENST00000266557.4
|
CD27
|
CD27 molecule |
chr20_+_3796288 | 2.98 |
ENST00000439880.6
ENST00000245960.10 |
CDC25B
|
cell division cycle 25B |
chr11_+_117986386 | 2.96 |
ENST00000227752.8
|
IL10RA
|
interleukin 10 receptor subunit alpha |
chr20_+_63736651 | 2.96 |
ENST00000487026.5
ENST00000309546.8 ENST00000480139.5 |
LIME1
|
Lck interacting transmembrane adaptor 1 |
chr5_+_136058849 | 2.95 |
ENST00000508076.5
|
TGFBI
|
transforming growth factor beta induced |
chr16_-_88977196 | 2.94 |
ENST00000268679.9
|
CBFA2T3
|
CBFA2/RUNX1 partner transcriptional co-repressor 3 |
chr17_+_45221993 | 2.92 |
ENST00000328118.7
|
FMNL1
|
formin like 1 |
chr22_+_22697789 | 2.90 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr11_+_64206663 | 2.90 |
ENST00000544997.5
ENST00000345728.10 ENST00000279227.9 |
FERMT3
|
fermitin family member 3 |
chr6_-_31582415 | 2.88 |
ENST00000429299.3
ENST00000446745.2 |
LTB
|
lymphotoxin beta |
chr1_-_206923183 | 2.88 |
ENST00000525793.5
|
FCMR
|
Fc fragment of IgM receptor |
chr1_-_169711603 | 2.86 |
ENST00000236147.6
ENST00000650983.1 |
SELL
|
selectin L |
chr2_-_86790900 | 2.86 |
ENST00000283635.8
|
CD8A
|
CD8a molecule |
chr17_+_45221854 | 2.84 |
ENST00000331495.8
|
FMNL1
|
formin like 1 |
chr1_-_206923242 | 2.80 |
ENST00000529560.1
|
FCMR
|
Fc fragment of IgM receptor |
chr1_+_206583255 | 2.80 |
ENST00000581888.1
|
RASSF5
|
Ras association domain family member 5 |
chr17_+_78168565 | 2.79 |
ENST00000225777.8
ENST00000585591.5 ENST00000589711.1 ENST00000588282.5 ENST00000589168.1 |
SYNGR2
|
synaptogyrin 2 |
chr19_-_2292024 | 2.77 |
ENST00000585527.1
|
LINGO3
|
leucine rich repeat and Ig domain containing 3 |
chr22_+_22686724 | 2.74 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
chr14_-_106511856 | 2.74 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
chr22_+_22747383 | 2.74 |
ENST00000390311.3
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
chr14_-_106811131 | 2.73 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
chr17_+_36210924 | 2.72 |
ENST00000615418.4
|
CCL4L2
|
C-C motif chemokine ligand 4 like 2 |
chr14_-_106185387 | 2.72 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
chr6_-_32763522 | 2.72 |
ENST00000435145.6
ENST00000437316.7 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
chr19_+_7669043 | 2.72 |
ENST00000221515.6
|
RETN
|
resistin |
chr1_+_117606040 | 2.71 |
ENST00000369448.4
|
TENT5C
|
terminal nucleotidyltransferase 5C |
chr14_-_106269133 | 2.71 |
ENST00000390609.3
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
chr14_-_106025628 | 2.71 |
ENST00000631943.1
|
IGHV7-4-1
|
immunoglobulin heavy variable 7-4-1 |
chr1_+_27879638 | 2.69 |
ENST00000456990.1
|
THEMIS2
|
thymocyte selection associated family member 2 |
chr11_-_417385 | 2.68 |
ENST00000332725.7
|
SIGIRR
|
single Ig and TIR domain containing |
chr6_-_24910695 | 2.68 |
ENST00000643623.1
ENST00000538035.6 ENST00000647136.1 |
RIPOR2
|
RHO family interacting cell polarization regulator 2 |
chr9_-_114387973 | 2.67 |
ENST00000374088.8
|
AKNA
|
AT-hook transcription factor |
chr4_+_153466324 | 2.65 |
ENST00000409663.7
ENST00000409959.8 |
TMEM131L
|
transmembrane 131 like |
chr2_-_89010515 | 2.65 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr2_-_89143133 | 2.64 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr2_-_157439403 | 2.63 |
ENST00000418920.5
|
CYTIP
|
cytohesin 1 interacting protein |
chr22_+_22922594 | 2.63 |
ENST00000390331.3
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr22_+_22880706 | 2.63 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
chr7_+_80646436 | 2.61 |
ENST00000419819.2
|
CD36
|
CD36 molecule |
chr14_-_105987068 | 2.60 |
ENST00000390594.3
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
chr1_+_207454230 | 2.59 |
ENST00000367058.7
ENST00000367059.3 ENST00000367057.8 |
CR2
|
complement C3d receptor 2 |
chr7_+_50304693 | 2.58 |
ENST00000331340.8
ENST00000413698.5 ENST00000612658.4 ENST00000359197.9 ENST00000349824.8 ENST00000343574.9 ENST00000357364.8 ENST00000440768.6 ENST00000346667.8 ENST00000615491.4 |
IKZF1
|
IKAROS family zinc finger 1 |
chr6_-_32763466 | 2.57 |
ENST00000427449.1
ENST00000411527.5 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
chr2_+_68734861 | 2.57 |
ENST00000467265.5
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr2_+_90100235 | 2.57 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr6_+_42746958 | 2.55 |
ENST00000614467.4
|
BICRAL
|
BRD4 interacting chromatin remodeling complex associated protein like |
chr17_+_82235769 | 2.54 |
ENST00000619321.2
|
SLC16A3
|
solute carrier family 16 member 3 |
chr22_+_22369601 | 2.53 |
ENST00000390295.3
|
IGLV7-46
|
immunoglobulin lambda variable 7-46 |
chr16_-_31202733 | 2.53 |
ENST00000350605.4
ENST00000247470.10 |
PYCARD
|
PYD and CARD domain containing |
chr9_-_136742903 | 2.53 |
ENST00000474369.1
ENST00000497771.6 ENST00000527229.5 |
LCN10
|
lipocalin 10 |
chr22_+_24427587 | 2.52 |
ENST00000337539.12
|
ADORA2A
|
adenosine A2a receptor |
chr10_-_101588126 | 2.49 |
ENST00000339310.7
ENST00000299206.8 ENST00000413344.5 ENST00000429502.1 ENST00000430045.1 ENST00000370172.5 ENST00000370162.8 ENST00000628479.2 |
POLL
|
DNA polymerase lambda |
chr11_-_33869816 | 2.48 |
ENST00000395833.7
|
LMO2
|
LIM domain only 2 |
chr6_+_36027773 | 2.47 |
ENST00000468133.5
|
MAPK14
|
mitogen-activated protein kinase 14 |
chr1_+_12166978 | 2.47 |
ENST00000376259.7
ENST00000536782.2 |
TNFRSF1B
|
TNF receptor superfamily member 1B |
chr11_-_441964 | 2.46 |
ENST00000332826.7
|
ANO9
|
anoctamin 9 |
chr12_+_64610458 | 2.45 |
ENST00000542104.6
|
RASSF3
|
Ras association domain family member 3 |
chr17_+_4710622 | 2.45 |
ENST00000574954.5
ENST00000269260.7 ENST00000346341.6 ENST00000572457.5 ENST00000381488.10 ENST00000412477.7 ENST00000571428.5 ENST00000575877.5 |
ARRB2
|
arrestin beta 2 |
chr7_+_12686998 | 2.44 |
ENST00000439721.1
|
ARL4A
|
ADP ribosylation factor like GTPase 4A |
chr14_-_106411021 | 2.43 |
ENST00000390618.2
|
IGHV3-38
|
immunoglobulin heavy variable 3-38 (non-functional) |
chrX_+_124346544 | 2.41 |
ENST00000371139.9
|
SH2D1A
|
SH2 domain containing 1A |
chr2_+_218129277 | 2.40 |
ENST00000428565.1
|
CXCR2
|
C-X-C motif chemokine receptor 2 |
chr22_-_23754376 | 2.40 |
ENST00000398465.3
ENST00000248948.4 |
VPREB3
|
V-set pre-B cell surrogate light chain 3 |
chr17_-_63932261 | 2.40 |
ENST00000349817.2
ENST00000006750.8 ENST00000392795.7 |
CD79B
|
CD79b molecule |
chr17_+_36211055 | 2.40 |
ENST00000617405.5
ENST00000617416.4 ENST00000613173.4 ENST00000620732.4 ENST00000620098.4 ENST00000620576.4 ENST00000620055.4 ENST00000610565.4 ENST00000620250.1 |
CCL4L2
|
C-C motif chemokine ligand 4 like 2 |
chr19_+_17527250 | 2.40 |
ENST00000599164.6
ENST00000449408.6 ENST00000600871.5 ENST00000599124.1 |
NIBAN3
|
niban apoptosis regulator 3 |
chr19_+_41877267 | 2.39 |
ENST00000221972.8
ENST00000597454.1 ENST00000444740.2 |
CD79A
|
CD79a molecule |
chr6_-_24911029 | 2.39 |
ENST00000259698.9
ENST00000644621.1 ENST00000644411.1 |
RIPOR2
|
RHO family interacting cell polarization regulator 2 |
chr15_-_22160868 | 2.39 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
chr22_+_22030934 | 2.37 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr2_+_68774782 | 2.35 |
ENST00000409030.7
ENST00000409220.5 |
ARHGAP25
|
Rho GTPase activating protein 25 |
chr22_+_37282464 | 2.34 |
ENST00000402997.5
ENST00000405206.3 ENST00000248901.11 |
CYTH4
|
cytohesin 4 |
chrX_-_154014246 | 2.34 |
ENST00000444254.1
|
IRAK1
|
interleukin 1 receptor associated kinase 1 |
chr4_+_40196907 | 2.34 |
ENST00000622175.4
ENST00000619474.4 ENST00000615083.4 ENST00000610353.4 ENST00000614836.1 |
RHOH
|
ras homolog family member H |
chr16_+_70646536 | 2.33 |
ENST00000288098.6
|
IL34
|
interleukin 34 |
chr2_+_68774921 | 2.32 |
ENST00000497079.5
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr14_-_106422175 | 2.32 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
chr1_+_32251239 | 2.32 |
ENST00000373564.7
ENST00000482949.5 ENST00000336890.10 ENST00000495610.6 |
LCK
|
LCK proto-oncogene, Src family tyrosine kinase |
chr7_+_80646305 | 2.31 |
ENST00000426978.5
ENST00000432207.5 |
CD36
|
CD36 molecule |
chr5_-_176899332 | 2.31 |
ENST00000292432.10
|
HK3
|
hexokinase 3 |
chr14_-_106374129 | 2.30 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
chr12_-_108633864 | 2.30 |
ENST00000550948.2
|
SELPLG
|
selectin P ligand |
chr2_+_90220727 | 2.29 |
ENST00000471857.2
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
chr2_+_48314637 | 2.28 |
ENST00000413569.5
ENST00000340553.8 |
FOXN2
|
forkhead box N2 |
chr14_-_106108453 | 2.27 |
ENST00000632950.2
|
IGHV5-10-1
|
immunoglobulin heavy variable 5-10-1 |
chr14_-_106360320 | 2.26 |
ENST00000390615.2
|
IGHV3-33
|
immunoglobulin heavy variable 3-33 |
chr6_+_36027796 | 2.25 |
ENST00000229794.9
|
MAPK14
|
mitogen-activated protein kinase 14 |
chr19_+_6772699 | 2.23 |
ENST00000602142.6
ENST00000304076.6 ENST00000596764.5 |
VAV1
|
vav guanine nucleotide exchange factor 1 |
chr22_+_22195753 | 2.22 |
ENST00000390285.4
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
chr3_+_191329020 | 2.22 |
ENST00000392456.4
|
CCDC50
|
coiled-coil domain containing 50 |
chr17_+_70169516 | 2.21 |
ENST00000243457.4
|
KCNJ2
|
potassium inwardly rectifying channel subfamily J member 2 |
chr2_-_88992903 | 2.20 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr5_+_56815534 | 2.20 |
ENST00000399503.4
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1 |
chr11_+_64340191 | 2.19 |
ENST00000356786.10
|
CCDC88B
|
coiled-coil domain containing 88B |
chr22_+_36860973 | 2.19 |
ENST00000447071.5
ENST00000397147.7 ENST00000248899.11 |
NCF4
|
neutrophil cytosolic factor 4 |
chr15_-_40307910 | 2.18 |
ENST00000543785.3
ENST00000260402.8 |
PLCB2
|
phospholipase C beta 2 |
chr4_-_73982019 | 2.18 |
ENST00000296029.4
|
PF4
|
platelet factor 4 |
chr4_-_80073170 | 2.17 |
ENST00000403729.7
|
ANTXR2
|
ANTXR cell adhesion molecule 2 |
chr14_-_106675544 | 2.16 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
chr22_+_44180915 | 2.16 |
ENST00000444313.8
ENST00000416291.5 |
PARVG
|
parvin gamma |
chr2_+_68734773 | 2.16 |
ENST00000409202.8
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr2_-_89320146 | 2.13 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 |
chr10_-_72088972 | 2.11 |
ENST00000317376.8
ENST00000412663.5 |
SPOCK2
|
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2 |
chr6_+_36027677 | 2.10 |
ENST00000622903.4
ENST00000229795.7 |
MAPK14
|
mitogen-activated protein kinase 14 |
chr8_-_132760548 | 2.09 |
ENST00000519187.5
ENST00000523829.5 ENST00000677595.1 ENST00000356838.7 ENST00000377901.8 ENST00000519304.1 |
TMEM71
|
transmembrane protein 71 |
chr15_+_74541200 | 2.07 |
ENST00000622429.1
ENST00000346246.10 |
ARID3B
|
AT-rich interaction domain 3B |
chr2_-_75199511 | 2.07 |
ENST00000305249.10
|
TACR1
|
tachykinin receptor 1 |
chr8_-_100706763 | 2.07 |
ENST00000517990.5
|
PABPC1
|
poly(A) binding protein cytoplasmic 1 |
chrX_+_1268807 | 2.06 |
ENST00000381524.8
ENST00000381529.9 ENST00000412290.6 |
CSF2RA
|
colony stimulating factor 2 receptor subunit alpha |
chr12_-_53207241 | 2.06 |
ENST00000267082.10
ENST00000549086.2 |
ITGB7
|
integrin subunit beta 7 |
chr2_+_218126012 | 2.05 |
ENST00000454148.1
ENST00000318507.7 |
CXCR2
|
C-X-C motif chemokine receptor 2 |
chr11_-_61429235 | 2.04 |
ENST00000626926.1
ENST00000448745.5 |
CPSF7
|
cleavage and polyadenylation specific factor 7 |
chr7_+_80646347 | 2.04 |
ENST00000413265.5
|
CD36
|
CD36 molecule |
chr1_+_3857261 | 2.04 |
ENST00000625756.2
ENST00000338895.7 |
DFFB
|
DNA fragmentation factor subunit beta |
chr19_+_18001117 | 2.03 |
ENST00000379656.7
|
ARRDC2
|
arrestin domain containing 2 |
chr16_+_81739027 | 2.03 |
ENST00000566191.5
ENST00000565272.5 ENST00000563954.5 ENST00000565054.5 |
ENSG00000261218.5
PLCG2
|
novel transcript phospholipase C gamma 2 |
chr16_+_3046552 | 2.02 |
ENST00000336577.9
|
MMP25
|
matrix metallopeptidase 25 |
chr14_+_30874541 | 2.02 |
ENST00000396618.9
ENST00000644874.2 ENST00000555117.2 ENST00000475087.5 |
COCH
|
cochlin |
chr2_+_232697362 | 2.00 |
ENST00000482666.5
ENST00000483164.5 ENST00000490229.5 ENST00000464805.5 ENST00000489328.1 |
GIGYF2
|
GRB10 interacting GYF protein 2 |
chr16_+_27402167 | 2.00 |
ENST00000564089.5
ENST00000337929.8 |
IL21R
|
interleukin 21 receptor |
chr12_-_14950606 | 2.00 |
ENST00000536592.5
|
ARHGDIB
|
Rho GDP dissociation inhibitor beta |
chr9_+_126860625 | 1.99 |
ENST00000319119.4
|
ZBTB34
|
zinc finger and BTB domain containing 34 |
chr17_-_8965674 | 1.99 |
ENST00000447110.6
ENST00000611902.4 ENST00000616147.4 ENST00000623421.3 |
PIK3R5
|
phosphoinositide-3-kinase regulatory subunit 5 |
chr17_-_3964415 | 1.98 |
ENST00000397043.7
ENST00000397035.7 ENST00000397041.8 |
ATP2A3
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 |
chr14_-_106117159 | 1.98 |
ENST00000390601.3
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 |
chr15_-_21718245 | 1.97 |
ENST00000630556.1
|
ENSG00000281179.1
|
novel gene identicle to IGHV1OR15-1 |
chr22_+_22427517 | 1.97 |
ENST00000390300.2
|
IGLV5-37
|
immunoglobulin lambda variable 5-37 |
chr14_+_21918161 | 1.96 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
chr3_-_27722316 | 1.96 |
ENST00000449599.4
|
EOMES
|
eomesodermin |
chr9_-_114388020 | 1.96 |
ENST00000312033.3
|
AKNA
|
AT-hook transcription factor |
chr17_-_35880350 | 1.95 |
ENST00000605140.6
ENST00000651122.1 ENST00000603197.6 |
CCL5
|
C-C motif chemokine ligand 5 |
chr2_-_89213917 | 1.95 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr1_+_156150008 | 1.95 |
ENST00000355014.6
|
SEMA4A
|
semaphorin 4A |
chr6_+_42915989 | 1.95 |
ENST00000441198.4
ENST00000446507.5 ENST00000616441.2 |
PTCRA
|
pre T cell antigen receptor alpha |
chrX_+_1268828 | 1.93 |
ENST00000432318.8
ENST00000381509.8 ENST00000494969.7 ENST00000355805.7 ENST00000355432.8 |
CSF2RA
|
colony stimulating factor 2 receptor subunit alpha |
chr1_+_3857452 | 1.93 |
ENST00000378209.8
|
DFFB
|
DNA fragmentation factor subunit beta |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 7.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.5 | 6.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
1.3 | 6.4 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
1.3 | 7.5 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
1.2 | 3.7 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
1.2 | 3.6 | GO:0002818 | intracellular defense response(GO:0002818) |
1.2 | 3.5 | GO:0010933 | macrophage tolerance induction(GO:0010931) regulation of macrophage tolerance induction(GO:0010932) positive regulation of macrophage tolerance induction(GO:0010933) |
1.2 | 3.5 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
1.1 | 6.9 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
1.1 | 4.4 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
1.1 | 2.2 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
1.1 | 3.2 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
1.0 | 2.1 | GO:0035106 | operant conditioning(GO:0035106) |
1.0 | 7.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.0 | 4.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.9 | 2.8 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.9 | 5.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.9 | 0.9 | GO:0002445 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
0.8 | 2.5 | GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus(GO:0002876) |
0.8 | 5.1 | GO:1903904 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
0.8 | 4.2 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.8 | 135.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.8 | 9.4 | GO:0072564 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.8 | 1.6 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.8 | 3.9 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.8 | 0.8 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
0.7 | 3.0 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.7 | 3.6 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.7 | 1.4 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.7 | 2.1 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.7 | 2.8 | GO:1900163 | regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
0.7 | 2.8 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.6 | 3.9 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.6 | 3.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.6 | 0.6 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
0.6 | 2.5 | GO:2001226 | negative regulation of anion channel activity(GO:0010360) negative regulation of chloride transport(GO:2001226) |
0.6 | 4.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.6 | 1.8 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.6 | 5.0 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.6 | 5.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.5 | 1.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.5 | 1.6 | GO:1902905 | positive regulation of fibril organization(GO:1902905) |
0.5 | 2.0 | GO:0032904 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.5 | 1.5 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
0.5 | 4.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.5 | 0.9 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.5 | 2.3 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.5 | 1.4 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of type IV hypersensitivity(GO:0001808) negative regulation of hypersensitivity(GO:0002884) |
0.5 | 1.4 | GO:0071626 | mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
0.5 | 1.4 | GO:2000625 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
0.5 | 1.4 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.4 | 1.8 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.4 | 2.2 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.4 | 0.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.4 | 1.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.4 | 9.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.4 | 1.3 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.4 | 1.3 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.4 | 2.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.4 | 1.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.4 | 2.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.4 | 4.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.4 | 1.2 | GO:1903970 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
0.4 | 1.6 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.4 | 1.2 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.4 | 3.5 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.4 | 5.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.4 | 1.2 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
0.4 | 0.8 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.4 | 2.7 | GO:0032252 | secretory granule localization(GO:0032252) |
0.4 | 1.5 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.4 | 2.6 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.4 | 1.1 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.4 | 1.1 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.4 | 1.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.4 | 1.5 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.4 | 2.9 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.4 | 76.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.4 | 2.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.4 | 2.5 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.3 | 2.4 | GO:2000771 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.3 | 1.0 | GO:0032759 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.3 | 1.4 | GO:0002384 | hepatic immune response(GO:0002384) |
0.3 | 2.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.3 | 2.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 3.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 2.0 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.3 | 0.7 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.3 | 0.7 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.3 | 0.7 | GO:0052031 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.3 | 6.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 3.6 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.3 | 0.6 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.3 | 2.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 0.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.3 | 1.3 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.3 | 1.2 | GO:0052227 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.3 | 1.2 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 2.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 0.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 1.5 | GO:0060022 | hard palate development(GO:0060022) |
0.3 | 0.6 | GO:0070235 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of activation-induced cell death of T cells(GO:0070235) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.3 | 0.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 1.7 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 1.7 | GO:2000330 | positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.3 | 0.6 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
0.3 | 2.0 | GO:0061056 | sclerotome development(GO:0061056) |
0.3 | 0.3 | GO:0090094 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
0.3 | 0.3 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.3 | 1.1 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.3 | 1.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 2.5 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
0.3 | 0.8 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.3 | 23.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 1.3 | GO:2000176 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
0.3 | 3.1 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) negative regulation of immature T cell proliferation(GO:0033087) |
0.3 | 4.6 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.3 | 1.5 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.3 | 1.3 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.3 | 1.3 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.3 | 1.5 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.2 | 1.0 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 0.7 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.2 | 0.7 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.2 | 1.0 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.2 | 1.0 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.2 | 0.7 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 1.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.2 | 1.0 | GO:0035853 | chromosome passenger complex localization to spindle midzone(GO:0035853) |
0.2 | 1.4 | GO:0006154 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
0.2 | 4.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 2.9 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 1.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.2 | 1.4 | GO:1990539 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.2 | 1.2 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.2 | 0.2 | GO:2000974 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
0.2 | 1.1 | GO:0002924 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 10.8 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 2.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.2 | GO:2000405 | negative regulation of T cell migration(GO:2000405) |
0.2 | 4.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.2 | 2.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 1.3 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.2 | 3.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 3.8 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
0.2 | 1.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.2 | 1.3 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.2 | 4.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 1.3 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
0.2 | 1.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.6 | GO:1990579 | protein trans-autophosphorylation(GO:0036290) peptidyl-serine trans-autophosphorylation(GO:1990579) |
0.2 | 3.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 1.7 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 1.0 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.2 | 1.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.2 | 4.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 1.8 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 0.8 | GO:0002524 | hypersensitivity(GO:0002524) |
0.2 | 2.4 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 1.0 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.2 | 1.0 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.6 | GO:0070078 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
0.2 | 2.0 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.2 | 1.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.2 | 0.4 | GO:0060197 | cloacal septation(GO:0060197) |
0.2 | 1.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 1.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 0.8 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.2 | 1.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 0.2 | GO:0002461 | peripheral T cell tolerance induction(GO:0002458) tolerance induction dependent upon immune response(GO:0002461) peripheral tolerance induction(GO:0002465) |
0.2 | 3.3 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.2 | 0.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.2 | 0.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 1.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 4.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 2.6 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 0.8 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.2 | 5.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 3.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 2.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 1.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 0.9 | GO:0060754 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 8.0 | GO:0050779 | RNA destabilization(GO:0050779) |
0.2 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 2.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 1.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 1.2 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 0.7 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
0.2 | 1.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.2 | 1.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 0.7 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.2 | 0.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 1.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.5 | GO:0048561 | establishment of organ orientation(GO:0048561) |
0.2 | 0.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 2.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 2.4 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) negative regulation of membrane potential(GO:0045837) |
0.2 | 0.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.2 | 0.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 0.8 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.2 | 0.8 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 1.8 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.2 | 0.8 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 0.3 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.2 | 0.3 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.2 | 2.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 1.1 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 3.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.2 | 1.2 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.2 | 0.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.2 | 0.6 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.2 | 0.9 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.2 | 3.1 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.2 | 0.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 0.9 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.2 | 1.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.4 | GO:0015938 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
0.1 | 0.3 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.1 | 0.3 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.7 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.1 | 3.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.7 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 1.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 2.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 1.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 1.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 2.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 2.0 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 2.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.6 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.8 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 3.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 6.5 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 2.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 1.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 3.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.8 | GO:0015677 | copper ion import(GO:0015677) |
0.1 | 2.0 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.1 | 1.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 2.3 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.3 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 1.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.3 | GO:0036292 | DNA rewinding(GO:0036292) |
0.1 | 3.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.5 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.1 | 1.7 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 4.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 1.0 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.1 | 1.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 3.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 0.5 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.2 | GO:0032571 | response to vitamin K(GO:0032571) |
0.1 | 0.9 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.4 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.1 | 2.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.4 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.4 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.1 | 0.5 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.1 | 0.4 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.1 | 0.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 7.2 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 1.4 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.1 | 6.8 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 0.5 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.1 | 0.7 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.6 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.3 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
0.1 | 0.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 1.7 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.3 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 2.4 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 1.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 1.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.6 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.1 | 0.5 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
0.1 | 2.1 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 1.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 3.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.5 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
0.1 | 6.7 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 1.2 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.3 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.1 | 3.9 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.1 | 1.8 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.5 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.1 | 0.9 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 3.0 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 4.3 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.1 | 0.4 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.1 | 0.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.3 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.1 | 6.3 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 0.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 0.8 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.7 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.1 | 4.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 2.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 1.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.2 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.1 | 7.8 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.7 | GO:2000042 | DNA replication, synthesis of RNA primer(GO:0006269) negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.8 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.4 | GO:0018277 | protein deamination(GO:0018277) |
0.1 | 0.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.4 | GO:2000314 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.1 | 0.3 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 1.0 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.5 | GO:1904073 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.1 | 0.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.2 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.1 | 1.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.1 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.1 | 1.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.4 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.1 | 1.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.1 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.5 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 0.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.7 | GO:0038107 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.2 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.1 | 0.7 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.6 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.3 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.1 | 0.8 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 2.0 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.1 | 0.4 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 1.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 1.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.4 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
0.1 | 0.3 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.1 | 1.6 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.1 | 0.7 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.2 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.1 | 1.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 1.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.4 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.1 | 0.4 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.7 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 0.7 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 1.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.4 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 0.4 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 2.4 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.4 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
0.1 | 0.9 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 1.3 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.1 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.9 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 1.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 1.2 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.3 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.7 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.3 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.1 | 16.2 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 0.5 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.1 | 0.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.1 | 0.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.2 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.1 | 1.2 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 2.4 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.3 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.2 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.5 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.3 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 1.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.2 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.1 | 0.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.2 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.1 | 0.2 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.1 | 0.2 | GO:1901874 | negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 1.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 1.2 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.4 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) positive regulation of superoxide anion generation(GO:0032930) |
0.1 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 1.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.6 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 1.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 1.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.9 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 0.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.5 | GO:0019049 | negative regulation of cardiac muscle adaptation(GO:0010616) evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) negative regulation of lung blood pressure(GO:0061767) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.1 | 0.9 | GO:0046632 | alpha-beta T cell differentiation(GO:0046632) |
0.1 | 3.9 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 3.6 | GO:0030217 | T cell differentiation(GO:0030217) |
0.1 | 0.1 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.1 | 1.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 2.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.1 | 0.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.3 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.3 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 1.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 6.3 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 0.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 2.0 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.2 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 0.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 1.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.5 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 1.2 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) regulation of type B pancreatic cell apoptotic process(GO:2000674) negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 2.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.0 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 2.3 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.3 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.0 | 1.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.2 | GO:1902904 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.0 | 0.3 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.3 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.0 | 0.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 1.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.3 | GO:0072752 | cellular response to rapamycin(GO:0072752) response to rapamycin(GO:1901355) |
0.0 | 0.5 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 1.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.3 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.0 | 0.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 1.6 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 1.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.5 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 6.1 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 7.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.2 | GO:1902943 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) |
0.0 | 0.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.1 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
0.0 | 0.2 | GO:1900737 | negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.0 | 1.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 8.5 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.0 | 0.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.1 | GO:0032258 | CVT pathway(GO:0032258) |
0.0 | 0.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 1.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.0 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.0 | 0.9 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.3 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 0.2 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.1 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
0.0 | 0.2 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.0 | 3.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.4 | GO:0009304 | tRNA transcription(GO:0009304) 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.4 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.0 | 0.3 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 6.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.5 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.6 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.0 | 0.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.0 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) positive regulation of mitochondrial fusion(GO:0010636) |
0.0 | 0.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 1.8 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.4 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 4.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.1 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
0.0 | 0.4 | GO:1902416 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.0 | 0.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.1 | GO:0090285 | regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.0 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.0 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.7 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.4 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.2 | GO:0071362 | cellular response to ether(GO:0071362) |
0.0 | 0.3 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 2.3 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.0 | 0.1 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.0 | 0.2 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.0 | 0.4 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.1 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.0 | 0.2 | GO:0016036 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
0.0 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 1.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) |
0.0 | 0.1 | GO:1990523 | bone regeneration(GO:1990523) |
0.0 | 0.2 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.0 | 0.2 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.0 | 0.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.9 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.0 | 0.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.3 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.1 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.0 | 0.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.7 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.1 | GO:0032660 | regulation of interleukin-17 production(GO:0032660) |
0.0 | 0.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.6 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.3 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.3 | GO:0032264 | IMP salvage(GO:0032264) |
0.0 | 0.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 0.5 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.0 | 0.7 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 0.5 | GO:0000732 | strand displacement(GO:0000732) |
0.0 | 0.8 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 1.3 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.6 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 1.9 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.3 | GO:2000345 | regulation of hepatocyte proliferation(GO:2000345) |
0.0 | 0.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.2 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.0 | 2.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 1.0 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 1.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.1 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.0 | 0.1 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.3 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.3 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.2 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.0 | 0.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
0.0 | 0.2 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.0 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) negative regulation of natural killer cell cytokine production(GO:0002728) |
0.0 | 0.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.3 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.0 | 0.5 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.0 | 1.0 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 1.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 1.5 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 0.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.2 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.0 | 0.1 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.0 | 0.4 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 0.7 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0070378 | positive regulation of ERK5 cascade(GO:0070378) |
0.0 | 0.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.1 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.0 | 1.1 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.2 | GO:0008050 | female courtship behavior(GO:0008050) |
0.0 | 0.2 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.2 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.2 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.0 | 0.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.4 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.5 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.0 | 2.8 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.3 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.8 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.7 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.0 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.3 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.1 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.0 | 0.0 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.0 | 10.5 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.4 | GO:0042921 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.0 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.4 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 2.5 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.3 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.2 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.2 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.4 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.6 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.0 | 0.1 | GO:0000423 | macromitophagy(GO:0000423) response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.4 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.2 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.7 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.1 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.0 | 0.1 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.1 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 5.7 | GO:0071756 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
1.0 | 4.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.0 | 54.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
1.0 | 4.8 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.9 | 3.5 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.8 | 4.8 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.8 | 3.9 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.7 | 5.9 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.7 | 2.2 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.7 | 2.2 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) other organism cytoplasm(GO:0097679) |
0.7 | 4.1 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.6 | 7.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.6 | 3.1 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.6 | 3.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.5 | 5.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.5 | 7.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.5 | 2.5 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 2.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.5 | 3.7 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.5 | 0.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.4 | 2.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.4 | 5.1 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.4 | 3.5 | GO:0032010 | phagolysosome(GO:0032010) |
0.4 | 3.4 | GO:0035976 | AP1 complex(GO:0035976) |
0.4 | 6.8 | GO:0032059 | bleb(GO:0032059) |
0.4 | 7.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 1.1 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.3 | 3.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 1.0 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.3 | 1.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.3 | 0.6 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.3 | 1.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.3 | 0.9 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.3 | 7.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 2.2 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.3 | 5.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 1.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 3.6 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.3 | 1.8 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.2 | 2.7 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.2 | 0.7 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 0.7 | GO:0090651 | apical cytoplasm(GO:0090651) |
0.2 | 3.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.5 | GO:0014802 | terminal cisterna(GO:0014802) |
0.2 | 1.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 4.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 26.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.2 | 0.6 | GO:1990332 | Ire1 complex(GO:1990332) |
0.2 | 0.8 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 1.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 0.6 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 1.5 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.2 | 4.9 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.2 | 0.8 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.2 | 1.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.5 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
0.2 | 2.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.3 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.2 | 0.6 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.2 | 0.5 | GO:0075341 | host cell PML body(GO:0075341) |
0.2 | 0.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.6 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.2 | 1.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.8 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 0.7 | GO:0031905 | early endosome lumen(GO:0031905) |
0.1 | 1.6 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 2.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 2.1 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 4.6 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 8.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 3.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.4 | GO:0031310 | intrinsic component of vacuolar membrane(GO:0031310) |
0.1 | 1.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 1.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.4 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.5 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.1 | 0.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 1.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 3.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.3 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.1 | 1.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 1.9 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.8 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 2.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.1 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 2.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 1.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.4 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.1 | 0.7 | GO:1990031 | pinceau fiber(GO:1990031) |
0.1 | 23.8 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.1 | 0.7 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.3 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 16.0 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 0.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.5 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.3 | GO:0032116 | SMC loading complex(GO:0032116) |
0.1 | 11.8 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 2.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 18.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 1.1 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.1 | 1.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.6 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.5 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 17.0 | GO:0016605 | PML body(GO:0016605) |
0.1 | 2.7 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.1 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.1 | 0.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 3.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.4 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.1 | 1.3 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 2.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 2.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 5.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 5.1 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 2.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 0.6 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.5 | GO:0001652 | granular component(GO:0001652) |
0.1 | 4.8 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.9 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 2.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 2.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.3 | GO:0002133 | polycystin complex(GO:0002133) |
0.1 | 4.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.5 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.2 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.7 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 2.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.4 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 1.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 3.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 1.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 1.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 4.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.2 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.0 | 0.3 | GO:0019034 | viral replication complex(GO:0019034) |
0.0 | 6.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.3 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 3.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 2.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.7 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.0 | 0.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 1.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 8.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 1.0 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 3.6 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
0.0 | 1.3 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 2.7 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.3 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.0 | 0.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 1.8 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 7.6 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 5.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 1.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 7.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 2.5 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.1 | GO:0097545 | axonemal outer doublet(GO:0097545) |
0.0 | 1.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.5 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 1.8 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.0 | 0.2 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.2 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.2 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.0 | 0.7 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 1.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.6 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 1.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.0 | GO:0031906 | late endosome lumen(GO:0031906) |
0.0 | 45.9 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.0 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.0 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 1.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.3 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 2.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 1.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 1.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.3 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.4 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.9 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.3 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0035841 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.0 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.8 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.6 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.0 | GO:0044307 | dendritic branch(GO:0044307) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
1.6 | 4.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.4 | 7.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.3 | 7.5 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
1.2 | 3.7 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.0 | 5.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.0 | 3.9 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.9 | 65.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.8 | 3.3 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.8 | 9.4 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.7 | 8.2 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.7 | 159.7 | GO:0003823 | antigen binding(GO:0003823) |
0.7 | 4.8 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.6 | 10.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.6 | 2.5 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.6 | 2.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.6 | 1.8 | GO:0016154 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
0.6 | 0.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.6 | 2.3 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.6 | 2.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 4.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.5 | 7.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 1.6 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.5 | 1.6 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.5 | 1.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.5 | 1.4 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.5 | 3.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.5 | 1.8 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.4 | 2.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.4 | 2.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 1.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.4 | 3.8 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.4 | 1.3 | GO:0008434 | calcitriol receptor activity(GO:0008434) lithocholic acid receptor activity(GO:0038186) calcitriol binding(GO:1902098) lithocholic acid binding(GO:1902121) |
0.4 | 1.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.4 | 0.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.4 | 1.6 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
0.4 | 1.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.4 | 1.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.4 | 1.5 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.4 | 1.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.4 | 2.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 1.1 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
0.4 | 3.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 2.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.4 | 4.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 1.4 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.3 | 2.0 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.3 | 4.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 1.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 1.0 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.3 | 1.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 2.8 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.3 | 2.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 1.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 1.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 2.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 0.9 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.3 | 2.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 1.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 1.2 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.3 | 3.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.3 | 3.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 0.9 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.3 | 1.1 | GO:0030395 | lactose binding(GO:0030395) |
0.3 | 0.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 2.5 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 3.6 | GO:0004875 | complement receptor activity(GO:0004875) |
0.3 | 1.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 0.8 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.3 | 1.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 1.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.3 | 1.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 0.8 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.3 | 1.5 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.2 | 3.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.7 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.2 | 1.2 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.2 | 8.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 1.4 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.2 | 5.4 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 3.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 1.2 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.2 | 1.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 2.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 1.6 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.2 | 2.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 1.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 0.7 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.2 | 0.7 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 10.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 3.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 2.2 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 1.3 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.2 | 6.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 3.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 11.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 1.0 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 0.6 | GO:0033746 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
0.2 | 0.7 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.2 | 0.5 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.2 | 1.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 5.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 10.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 3.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.5 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.2 | 1.7 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 0.7 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.2 | 0.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 1.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 2.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.8 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 0.6 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 8.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 1.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 13.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.4 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
0.1 | 2.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 1.0 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 1.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 2.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 4.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 1.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 1.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.8 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.5 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.1 | 1.8 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 4.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 2.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.8 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 0.4 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
0.1 | 0.8 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 1.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 4.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 1.6 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 2.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.8 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 1.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 2.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.7 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 2.8 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.5 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.1 | 2.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 1.5 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 1.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 3.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 1.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 1.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 2.6 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 0.3 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.3 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.1 | 12.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.9 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 0.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 1.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.3 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.1 | 3.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 1.2 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.1 | 1.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 16.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.3 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.1 | 1.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 4.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.4 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.1 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 1.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 1.2 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 2.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.5 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.1 | 4.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0097689 | iron channel activity(GO:0097689) |
0.1 | 0.7 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 0.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.7 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 2.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 1.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 0.7 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 1.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.3 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.1 | 1.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 1.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 2.9 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 0.3 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 3.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.3 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.1 | 2.8 | GO:0070001 | aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.2 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.1 | 0.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.4 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.2 | GO:0034512 | box C/D snoRNA binding(GO:0034512) |
0.1 | 0.3 | GO:0010858 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 0.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.3 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 0.3 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 2.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 4.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 1.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 1.4 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 3.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.2 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.1 | 0.3 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.1 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 0.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.5 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 1.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.1 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.1 | 0.2 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.1 | 1.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 1.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 4.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 3.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 1.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.3 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 1.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.5 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 1.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 1.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 2.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 4.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.6 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.7 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 0.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.5 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 1.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.3 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.1 | GO:0045142 | triplex DNA binding(GO:0045142) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.5 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 2.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 1.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.7 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 1.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 2.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 2.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.0 | 0.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.8 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 3.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 1.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 2.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 7.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.0 | 0.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 19.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 3.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 2.1 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.0 | 0.1 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.0 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.1 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.0 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.1 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.0 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.0 | 3.3 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.8 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.0 | 1.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.0 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.0 | 6.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 1.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 1.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.8 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 1.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.1 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.0 | 5.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 2.4 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.0 | 0.5 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 11.2 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 3.5 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.0 | 0.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.2 | GO:0042835 | BRE binding(GO:0042835) |
0.0 | 0.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.0 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.0 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 1.0 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.1 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.0 | 0.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 1.2 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.4 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.0 | GO:0004335 | galactokinase activity(GO:0004335) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 45.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 19.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 22.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 5.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 24.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 7.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 11.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 17.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 0.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 6.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 5.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 6.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 6.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 4.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 8.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 10.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 4.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 7.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 5.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 7.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 3.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 6.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 3.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 3.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 3.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 4.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 3.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 2.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 4.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 2.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 6.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 2.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 3.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 12.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 6.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 2.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 3.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 4.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 3.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 2.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 1.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 3.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 1.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 1.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 3.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 1.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 1.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 1.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.7 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.5 | PID P53 REGULATION PATHWAY | p53 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 15.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 9.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.4 | 1.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.4 | 4.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 10.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 20.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 4.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 2.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 4.9 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 7.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 3.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 16.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 8.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 3.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 21.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 2.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 1.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 0.7 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.2 | 1.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 3.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 16.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 4.8 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 8.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 4.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 2.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 16.9 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 0.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 2.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 3.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 6.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 2.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 5.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 3.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 4.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 3.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 3.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 2.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 2.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 11.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 2.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 3.7 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 1.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 5.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 2.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 4.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 3.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 3.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 2.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 3.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 2.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 17.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.4 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.1 | 1.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 4.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.3 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 0.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 1.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 3.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 2.8 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 1.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 1.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 1.0 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 1.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 1.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 2.0 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 1.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 5.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 1.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 1.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.8 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 5.2 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 4.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 3.8 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.9 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.5 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 1.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 4.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 2.7 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.4 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 1.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 1.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.2 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.0 | 0.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME TRANSLATION | Genes involved in Translation |